Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trial (Q35179843)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trial |
scientific article |
Statements
1 reference
Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trial (English)
1 reference
Michael A Nauck
1 reference
Stefano Del Prato
1 reference
Juris J Meier
1 reference
Santiago Durán-García
1 reference
Katja Rohwedder
1 reference
Martina Elze
1 reference
Shamik J Parikh
1 reference
4 August 2011
1 reference
1 reference
1 reference
Identifiers
1 reference